Recombinant Vibrio vulnificus Uncharacterized protein YjeA (yjeA) is a bioengineered version of the native YjeA protein produced through heterologous expression systems. The protein is derived from Vibrio vulnificus, a pathogenic bacterium known for causing severe infections in humans. While YjeA remains functionally uncharacterized in the literature, its recombinant form is commercially available for research purposes, typically produced in E. coli with engineered purification tags .
Recombinant YjeA is primarily produced in E. coli due to its high yield and cost-effectiveness. Alternative systems (e.g., yeast, insect, or mammalian cells) may be employed to introduce post-translational modifications (PTMs) essential for structural or functional studies .
| Parameter | Value |
|---|---|
| Host Organism | E. coli (standard), yeast, insect/mammalian cells |
| Purification Tags | N-terminal 10xHis tag, C-terminal Myc tag |
| Purity | >85% (SDS-PAGE analysis) |
| Molecular Weight | Not explicitly stated in sources |
The recombinant protein corresponds to the yjeA gene (Uniprot ID: Q8DCX0) from V. vulnificus strain CMCP6. The amino acid sequence includes motifs for membrane localization and substrate recruitment, though functional domains remain undefined .
Partial Sequence (N-terminal):
MQADWKPTAS IEQLRQRAVL IANIRQFFAQ RGVLEVDTPA MSHATVTDIH LHTFQTEFVG PGYAQGRHLH LMTSPEFHMK RLLAAGSGCI YQMAKAFRNE ENGRHHNPEF TMLEWYRVGF DHHQLMDEMD DLLQLILKCG
As of 2025, no peer-reviewed studies have directly investigated YjeA’s biological role. Its classification as an "uncharacterized protein" reflects gaps in functional annotation. Potential roles inferred from homology to bacterial proteins include:
Membrane-associated processes: Sequence similarities suggest interactions with membrane-localized components .
Regulatory or chaperone functions: Structural motifs may imply involvement in protein folding or signal transduction.
Recombinant YjeA is used as a research tool for:
Antibody production: For generating YjeA-specific antisera .
Structural studies: Crystallization trials or NMR analysis (pending functional insights).
Protein interaction assays: Exploring binding partners via pull-down or co-IP experiments.
Functional ambiguity: No validated bioinformatics tools or experimental data link YjeA to specific pathways.
Limited strain representation: Commercially available YjeA originates from V. vulnificus CMCP6; strain-specific variations remain unexplored.
Functional genomics: Knockout mutant studies to assess phenotypic changes in V. vulnificus.
Proteomic analysis: Mass spectrometry-based identification of interacting proteins.
Structural biology: Determination of X-ray crystallography or cryo-EM structures to infer functional domains.
KEGG: vvy:VV3096
The yjeA gene in Vibrio vulnificus is located on the chromosome rather than on plasmids that often carry virulence-associated genes in this pathogen. Unlike the rtxA1 gene that encodes the MARTX toxin, which shows significant genetic variation across different isolates, the yjeA gene appears to be more conserved across biotypes . While not directly characterized in the available studies, analyses of Vibrio vulnificus genomic organization suggest that uncharacterized proteins like YjeA may be part of operons or genetic neighborhoods containing genes of related function. Researchers should examine flanking genes to identify potential functional relationships and regulatory elements that might control yjeA expression .
In vivo-induced antigen technology (IVIAT) represents an excellent methodological approach for determining whether proteins like YjeA are expressed during human infection. This technique identifies genes specifically expressed during human infections rather than laboratory conditions. The methodology involves:
Creating an expression library of V. vulnificus
Adsorbing convalescent-phase serum with in vitro-expressed V. vulnificus whole cells and lysates
Screening the expression library using the adsorbed serum
Analyzing reactive clones for antibody recognition
Sequencing and characterizing the identified genes
This approach has successfully identified several in vivo-expressed (ive) genes in V. vulnificus that contribute to virulence, including those encoding proteins involved in chemotaxis, signaling, metabolism, and transcriptional regulation . To determine if YjeA is expressed during infection, researchers should include it in such screening protocols to detect potential antibody recognition in convalescent serum.
While specific structural information about YjeA is not directly provided in the available studies, researchers approaching uncharacterized proteins in Vibrio vulnificus typically employ predictive bioinformatics tools to generate initial structural hypotheses. These include sequence homology modeling, secondary structure prediction, and identification of conserved domains.
For proteins like YjeA, researchers should investigate:
Presence of signal peptides indicating cellular localization
Transmembrane domains suggesting membrane association
Conserved motifs that might indicate enzymatic activity
Structural similarities to characterized proteins in related bacterial species
Computational approaches should be followed by experimental validation using techniques such as circular dichroism (CD) spectroscopy for secondary structure analysis, limited proteolysis for domain identification, and X-ray crystallography or cryo-electron microscopy for detailed structural characterization .
Determining the contribution of uncharacterized proteins like YjeA to virulence requires a multi-faceted approach that combines in vitro and in vivo methodologies:
Cytotoxicity assays: Measure lactate dehydrogenase (LDH) release from human cell lines (such as HeLa cells) exposed to wild-type and YjeA-deficient mutants.
Mouse infection models: Determine intraperitoneal 50% lethal dose (LD50) values for wild-type and mutant strains. Significant increases in LD50 (10-50 fold) would suggest virulence attenuation.
Intragastric infection models: Since V. vulnificus is primarily a food-borne pathogen, oral infection models can reveal the importance of YjeA in intestinal colonization and systemic spread.
Complementation studies: Reintroduce functional yjeA genes to confirm that observed phenotypes are directly attributable to the gene deletion.
These approaches have successfully identified key virulence factors in V. vulnificus, including PyrH, PurH, and HlyU, which when mutated showed dramatically reduced cytotoxicity and increased LD50 values in mice . Additionally, researchers should monitor bacterial growth in vivo to determine if YjeA is essential for survival in host environments or specifically contributes to virulence mechanisms.
Given that V. vulnificus demonstrates significant genetic recombination in virulence-associated genes like rtxA1, researchers investigating potential recombination in yjeA should implement a comprehensive experimental design:
Sample collection: Obtain diverse V. vulnificus isolates representing:
Different biotypes (1, 2, and 3)
Various serovars within biotype 2
Clinical and environmental sources
Geographic and temporal diversity
PCR amplification and sequencing: Generate complete sequences of yjeA genes from all isolates.
Sequence analysis: Apply recombination detection algorithms and phylogenetic analysis to identify:
Mosaic structures indicative of recombination
Potential donor sequences from related species or plasmids
Recombination hotspots
Functional characterization: Compare activities of variant proteins to determine if recombination events alter function.
This approach could reveal whether yjeA undergoes genetic rearrangement similar to rtxA1, which has been shown to generate toxin variants with different arrangements of effector domains through recombination with plasmid-borne genes or genes from other Vibrio species like V. anguillarum .
| Sample Source | Number of Strains | YjeA Variant Types | Recombination Evidence |
|---|---|---|---|
| Biotype 1 (Clinical) | 30-40 | To be determined | To be determined |
| Biotype 1 (Environmental) | 15-20 | To be determined | To be determined |
| Biotype 2 (Serovar E) | 30-35 | To be determined | To be determined |
| Biotype 2 (Other serovars) | 10-15 | To be determined | To be determined |
| Biotype 3 | 5-10 | To be determined | To be determined |
Expressing recombinant Vibrio vulnificus YjeA protein requires careful optimization of expression systems and conditions. Researchers should consider:
Expression system selection:
E. coli BL21(DE3) for high-yield expression
Cell-free systems for potentially toxic proteins
Eukaryotic systems if post-translational modifications are suspected
Expression vector optimization:
Incorporate affinity tags (His6, GST, MBP) for purification
Include protease cleavage sites for tag removal
Consider codon optimization for heterologous expression
Induction and growth conditions:
Test multiple induction temperatures (16°C, 25°C, 37°C)
Evaluate different inducer concentrations (0.1-1.0 mM IPTG)
Optimize media composition and growth phase at induction
Solubility enhancement strategies:
Co-expression with chaperones (GroEL/GroES, DnaK)
Addition of solubility-enhancing fusion partners
Inclusion of specific additives in lysis buffers
Purification protocol development:
Multi-step chromatography (affinity, ion exchange, size exclusion)
Optimized buffer conditions to maintain stability
Quality control via SDS-PAGE, Western blotting, and mass spectrometry
Researchers should conduct small-scale expression trials before scaling up to optimize conditions for maximum yield of properly folded protein . Thermal shift assays can help identify stabilizing buffer conditions for purified YjeA protein.
Identifying protein-protein interactions for uncharacterized proteins like YjeA requires systematic application of complementary techniques:
Pull-down assays: Express recombinant YjeA with affinity tags and identify binding partners from V. vulnificus lysates using mass spectrometry.
Bacterial two-hybrid systems: Test direct interactions with suspected partners based on genomic context or predicted function.
Co-immunoprecipitation: Generate antibodies against YjeA to pull down native protein complexes from V. vulnificus grown under various conditions.
Cross-linking mass spectrometry: Use chemical cross-linkers to stabilize transient interactions followed by mass spectrometry analysis.
Proximity-dependent biotin labeling: Express YjeA fused to enzymes like BirA or APEX2 to identify proteins in close proximity in vivo.
For interpreting results, researchers should prioritize interactions that are:
Reproducible across multiple techniques
Detected under infection-relevant conditions
Consistent with predicted subcellular localization
Functionally coherent with genomic context
This systematic approach has successfully identified interaction networks for virulence regulators like HlyU in V. vulnificus and could reveal whether YjeA participates in known virulence pathways or represents a novel virulence mechanism .
To investigate potential variation in YjeA expression across V. vulnificus strains, researchers should implement a comprehensive analysis protocol:
Strain collection preparation:
Include representatives of all biotypes (1, 2, 3)
Cover multiple serovars within biotype 2 (E, A, O3, O3/O4)
Include both clinical and environmental isolates
Growth condition optimization:
Standard laboratory media (LB with 2% NaCl)
Iron-limited conditions (mimicking host environment)
Serum-supplemented media
In vivo-mimicking conditions
Expression analysis techniques:
Quantitative RT-PCR for transcriptional analysis
Western blotting for protein-level comparison
Promoter-reporter fusions to monitor regulation
Data analysis and interpretation:
Normalize expression to housekeeping genes
Compare expression patterns with virulence phenotypes
Correlate expression with biotype/serovar classification
The approach should be modeled after successful comparative studies that have examined gene distribution across V. vulnificus biotypes, such as those that identified biotype-specific and serovar-specific DNA sequences . Current evidence shows that some virulence-associated genes are differentially distributed among biotypes and serovars, with some sequences being specific to biotype 2 (plasmid-borne) or specifically to serovar E strains (chromosomal) .
| Biotype/Serovar | Number of Strains | YjeA Expression Level | Correlation with Virulence |
|---|---|---|---|
| Biotype 1 | 50+ | To be determined | To be determined |
| Biotype 2, Serovar E | 30+ | To be determined | To be determined |
| Biotype 2, Other serovars | 10+ | To be determined | To be determined |
| Biotype 3 | 5+ | To be determined | To be determined |
When facing contradictory results regarding YjeA function, researchers should implement a systematic approach to data reconciliation:
Methodological comparison:
Evaluate differences in experimental systems (in vitro vs. in vivo)
Compare strain backgrounds used across studies
Assess technical variations in protocols
Consider statistical approaches and sample sizes
Conditional functionality assessment:
Test whether YjeA functions are condition-dependent
Evaluate effects of growth phase, temperature, salinity, and pH
Consider host factors that might influence protein activity
Strain-specific effects analysis:
Determine if contradictions arise from strain diversity
Compare clinical vs. environmental isolates
Assess biotype and serovar differences
Technical validation studies:
Replicate key experiments under standardized conditions
Use multiple complementary techniques to verify findings
Implement controls to rule out confounding factors
This systematic approach is particularly relevant for V. vulnificus research, as studies have shown unexpected variation in virulence gene function across strains. For example, research on the rtxA1 gene revealed that, contrary to expectations, the most common variant in clinical isolates encoded a toxin with reduced potency compared to variants from environmental strains . Such counterintuitive findings highlight the importance of thorough validation and contextual interpretation when studying uncharacterized proteins like YjeA.
To predict the function of uncharacterized proteins like YjeA, researchers should employ a comprehensive bioinformatic workflow:
Sequence homology analysis:
BLASTp searches against general and specialized databases
Position-Specific Iterated BLAST (PSI-BLAST) for distant homologs
Hidden Markov Model (HMM) searches using tools like HMMER
Structural prediction:
Secondary structure prediction (PSIPRED, JPred)
Tertiary structure modeling (AlphaFold2, I-TASSER)
Analysis of predicted binding pockets and active sites
Functional domain identification:
Conserved Domain Database (CDD) searches
InterProScan for functional classification
Motif identification using MEME and related tools
Genomic context analysis:
Operon structure prediction
Gene neighborhood conservation across Vibrio species
Identification of co-evolved gene clusters
Phylogenetic profiling:
Correlation of YjeA presence with specific phenotypes
Co-occurrence patterns with known virulence factors
Evolutionary rate analysis for selection pressure inference
This multi-faceted approach can generate testable hypotheses about YjeA function by leveraging information from various sources, similar to approaches used to identify the functions of novel virulence genes in V. vulnificus discovered through IVIAT . Researchers should prioritize experimental validation of predicted functions, particularly those suggesting roles in virulence or host adaptation.
Distinguishing direct from indirect effects in YjeA functional studies requires careful experimental design and controls:
Complementation analysis:
Reintroduce wild-type yjeA gene to verify phenotype restoration
Use point mutants affecting specific domains to map functional regions
Implement tightly controlled expression systems to prevent artifacts
Temporal analysis of effects:
Monitor time-course of phenotypic changes after gene deletion
Use inducible knockout systems to observe immediate effects
Compare acute versus long-term adaptation to gene loss
Molecular pathway reconstruction:
Perform transcriptomic analysis of wild-type vs. knockout strains
Conduct metabolomic profiling to identify biochemical alterations
Use phosphoproteomic approaches to detect signaling changes
Genetic interaction mapping:
Generate double mutants with genes in suspected pathways
Look for synthetic phenotypes or epistatic relationships
Identify suppressors of yjeA deletion phenotypes
This systematic approach is comparable to methods used to characterize other V. vulnificus virulence genes like pyrH, purH, and hlyU, where isogenic mutants showed dramatic effects on cytotoxicity and virulence . The most informative experiments combine phenotypic characterization with molecular analysis to establish mechanistic links between gene function and observed phenotypes.
Research on YjeA may provide valuable insights into the genetic basis of V. vulnificus biotype differentiation, which has significant implications for understanding pathogenicity:
Comparative genomic analysis:
Determine if yjeA sequence variants correlate with biotype classification
Analyze if yjeA is part of biotype-specific genomic islands
Assess evolutionary history of yjeA across the Vibrio genus
Functional characterization across biotypes:
Compare YjeA activity in biotype 1 (human pathogenic) vs. biotype 2 (eel virulent) strains
Assess if YjeA contributes to host specificity
Evaluate biotype-specific regulation of yjeA expression
Potential applications:
Development of biotype-specific diagnostic markers
Identification of targets for biotype-specific interventions
Improved understanding of evolution toward different host ranges
Current research demonstrates that V. vulnificus biotypes contain distinct genetic markers, with biotype 2 strains sharing plasmid-borne sequences not found in other biotypes, and serovar E strains containing unique chromosomal sequences . Understanding whether yjeA shows similar patterns or contributes to these distinctions could provide valuable insights into the evolution of host specificity and virulence in this pathogen.
| Biotype | Host Range | Characteristic Genetic Elements | Potential YjeA Role |
|---|---|---|---|
| Biotype 1 | Primarily human | Diverse genotypes | To be determined |
| Biotype 2 | Primarily eels | Shared plasmid-borne sequences | To be determined |
| Biotype 3 | Human | Hybrid genotype | To be determined |
Translating YjeA research into antimicrobial applications requires a structured drug discovery pathway:
Target validation:
Confirm essentiality or critical virulence contribution
Demonstrate conservation across clinical isolates
Verify absence of functional homologs in humans
Structure-based drug design:
Obtain high-resolution structure through X-ray crystallography or cryo-EM
Identify druggable pockets through computational analysis
Perform virtual screening of compound libraries
Fragment-based approaches:
Screen fragment libraries using NMR or thermal shift assays
Identify binding fragments with potential for optimization
Link or grow fragments to improve potency and specificity
Peptidomimetic inhibitor development:
Identify interaction partners and interface residues
Design peptides that mimic critical interaction surfaces
Optimize for stability, cell penetration, and target engagement
Validation in infection models:
Test candidate inhibitors in cell-based infection assays
Evaluate efficacy in animal models of V. vulnificus infection
Assess potential for resistance development
This approach mirrors successful antimicrobial development strategies targeting virulence factors in other pathogens and could be applicable to YjeA if it proves to be a critical factor in V. vulnificus pathogenesis . Given the high mortality rate associated with V. vulnificus infections and increasing antibiotic resistance concerns, novel therapeutic approaches targeting specific virulence factors represent a promising research direction.
Integrating YjeA research into the broader context of V. vulnificus pathogenesis requires a systems biology approach:
Regulatory network mapping:
Determine if YjeA is regulated by known virulence regulators (ToxRS, HlyU)
Identify conditions that co-regulate yjeA with established virulence factors
Map potential roles in signaling cascades affecting multiple virulence mechanisms
Multi-omics integration:
Combine transcriptomic, proteomic, and metabolomic data
Position YjeA within global molecular networks
Identify functional modules where YjeA participates
Host-pathogen interaction studies:
Evaluate YjeA's role during different stages of infection
Assess contributions to specific virulence phenotypes (adhesion, invasion, cytotoxicity)
Determine if YjeA interacts with host factors
Collaborative research frameworks:
Establish standardized strains and methodologies across laboratories
Create shared databases of virulence factor characterization
Implement consistent infection models for comparable results